coolvoidunknown-blog

[coolvoidunknown-blog]

Companion (Pet) Animal Healthcare Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Global companion animal healthcare market valued over US$ XX Bn in 2015 and projected to expand at CAGR of XX% over 2017 to 2024.

 Companion animals have been trusted for their companionship to the human throughout the history and keeping the companion animals healthy is a top priority for caregivers everywhere in the world. Several studies on human and companion animals’ interactions showed that owning a pet animal associated with positive health benefits. It is essential to veterinarians and caregivers to give utmost attention to companion animal health as companion animals are primary source of zoonotic diseases spread to humans and vice versa.

  A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/companion-pet-animal-healthcare-market/#ulp-4H8Z4LpNMLEuOnnx

  Companion animal healthcare market is expected to grow positively over the forecast period owing to increasing rates of pet ownership, rising life expectancy for companion animals, increased number of products for treating various companion animals ailments and advances in animals healthcare services and medicines. Apart from aforementioned factors, increasing per pet expenditure and pets are increasingly becoming part of the families in several emerging and developed economies prompting the key stakeholders to opt for better products and this in turn driving the animal health care market positively over the forecast period. However, increased treatment failures due to drug resistance, decreasing compliance to the treatments due to efficacy challenges of products expected to hinder the market revenue growth of companion animal healthcare market over the period of forecast.

 Companion animal healthcare market has been segmented on the basis of product type, companion animal type, distribution channel, and region

Based on product type, companion animal healthcare market segmented as follows:

·         Drugs

o    Antimicrobials

o    Ectoparasiticides

o    Endoparacitides

o    Endectoparaciticides

o    Others

·         Vaccines

·         Feed Additives

o    Nutritional Feed Additives

o    Medicinal Feed Additives

Based on companion animal type, companion animal healthcare market segmented as follows:

·         Feline

·         Canine

·         Equine

Based on dosage form, companion animal healthcare market segmented as follows:

·         Orals

·         Parenterals

·         Topicals

·         Others

Based on distribution channel, companion animal healthcare market segmented as follows:

·         Veterinary Pharmacies

·         Veterinary Hospitals

·         Veterinary Clinics

·         E-Commerce

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/companion-pet-animal-healthcare-market/#ulp-c654SbFYO64MsOhu

 Market for companion animal healthcare products is oligopolistic in nature with few players in the market holding significant market share. Large players in the market are Boehringer Ingelheim animal health and Zoetis, which occupies significant global presence and offer differential products in the global companion animal healthcare market. Moreover players in the companion animal healthcare market involved in mergers and acquisitions and coming up product innovation to garner larger market share in the market. For instance in 2011, Elanco acquired janseen to increase presence outside U.S. and  In 2014, Merial launched NextGaurd  form a soy based chew with an irresistible beef flavour for flea and tick control in dogs.

 Companion animal healthcare market has been segmented on the basis of region into North Americas, Europe, Asia Pacific, Latin America and Middle East and Africa. U.S. market dominated the companion animal healthcare market with largest market share in North America market with moderate growth rate. Europe companion animal market holds significant share in global companion animal healthcare market.  Increased product introduction in Europe like vaccine against Leishmania infantum , the causal agent of canine leishmaniosis which is significant breakthrough against zoonotic disease is one of the factors driving the market positively. Emerging markets in Latin Americas and Asia Pacific propelling the next phase of growth for companion animal products owing to rise in awareness regarding pet heath among caregivers, increased medicalization, and higher rate of pet ownership in the emerging markets.

 Some of the players in the animal healthcare market include Boehringer Ingelheim Gmbh, Zoetis Inc., Elanco, Merck & Co. Inc., Bayer Animal Health, Virbac SA, Ceva Sante Animale, Vetoquinol SA, Koninklijke DSM N.V.to name a few.

·         In July 2016, Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, received U.S. Food and Drug Administration’s approval for BRAVECTO (fluralaner topical solution) a topical treatment for fleas and ticks for both cats and dogs

·         In 2014, Virbac SA, signed ten years collaboration agreement with biopharmaceutical company Nexvet to develop of new monoclonal antibody-based veterinary medicines. The first medicine under the agreement between Virbac and Nexvet, NV-01, targets the control of pain associated with osteoarthritis in dogs.

  Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/companion-pet-animal-healthcare-market/#ulp-14mlyhjMGhVjZqa3

 Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012 to 2016) and forecast (2017 to 2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/companion-pet-animal-healthcare-market/

About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Contact to Precision Business Insights,

 Kemp House,

152 – 160 City Road,

London EC1V 2NX

 Email: sales@precisionbusinessinsights.com

 Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Colorectal Cancer Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Global Colorectal Cancer Diagnostics Market: By Test (FOB, CTC Tests, CEA Tests, KRAS Mutation Tests, Immunohistochemistry, Others), By End User ( Hospitals, Diagnostic Centers and Cancer Research Institutes)  and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 Global Colorectal Cancer Diagnostics market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 Market Outline: Colorectal Cancer Diagnostics Market

Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. Cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Some of the risk factors that can cause colorectal cancer are lifestyle changes, old age, genetic disorders, family history, and inflammatory bowel disease. Some of the symptoms of colorectal cancer are blood in stool, decrease in appetite, constipation, weight loss, nausea, bloating, and pelvic pain

 Market Dynamics: Colorectal Cancer Diagnostics Market

Global colorectal cancer diagnostics market is primarily driven by increase in prevalence of rectal and colon cancers globally. In addition, advent of novel screening tests for the cancer diagnosis such as DNA screening tests and other new techniques expected to bolster the market share over the forecast period. Furthermore, increase in geriatric population who are more prone to colorectal cancer and strengthening of government support for the screening of various types of cancers projected to boost the global colorectal cancer diagnostics market over the forecast period. However, lack of awareness and high cost of development coupled with stringent regulatory procedures for diagnostics expected to hamper the market share during the forecast period.

 A sample of this report is available upon request @

 https://www.precisionbusinessinsights.com/market-reports/colorectal-cancer-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx

 Market Scope: Colorectal Cancer Diagnostics Market

Colorectal cancer diagnostics market is segmented based on the type of condition, type of test, end user and geographical regions

Based on test, global colorectal cancer diagnostics market is segmented into the following:

·         FOB

·         CEA Tests

·         CTC Tests

·         Immunohistochemistry

·         KRAS Mutation Tests

·         Others

Based on end user, global colorectal cancer diagnostics market is segmented into the following:

·         Hospitals

·         Diagnostic Centers

·         Cancer Research Institutes

Based on the geographical regions, global colorectal cancer diagnostics market is segmented into the following:

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         The Middle East and Africa

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/colorectal-cancer-diagnostics-market/#ulp-c654SbFYO64MsOhu

 Market Summary: Colorectal Cancer Diagnostics Market

Global colorectal cancer diagnostics market is expected to grow at significant rates owing to growing prevalence of cancer. According to National Cancer Institute Colorectal cancer is third most occurring form of cancer worldwide. And in 2012 more than one million people are diagnosed with the colorectal cancer. Faecal Occult Blood (FOB) tests are projected to have the major share in diagnostics segment owing to the accuracy. Market players in colorectal cancer diagnostics are focusing on the development of the new techniques and expanding their product portfolio. Furthermore, various programs are imitated by the government and non-government organizations to screen the colorectal cancer in around the globe likely to positively impact the market growth furthermore.

 Regional Analysis:  Colorectal Cancer Diagnostics Market

Geographically, global colorectal cancer diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America colorectal cancer diagnostics market projected to have the significant growth rate owing to the increase in the rates of colorectal cancer and technological advancements in the diagnosis of the cancer. Europe colorectal cancer diagnostics market is expected to show propelled growth in global market owing the rise in R&D funding and healthcare expenditure in the region. Asia Pacific and Middle East and Africa markets projected to sluggish growth rates owing to the comparatively low colorectal cancer prevalence in the region. However, expansion of the international companies into the emerging Asian countries such as China and India expected to show lucrative growth opportunity in Asia Pacific region.

 Competition Assessment: Colorectal Cancer Diagnostics Market

Some of the players in the global colorectal cancer diagnostics market include:

·         Sysmex Corporation (Japan)

·         Illumina, Inc. (U.S.)

·         Rosetta Genomics Ltd. (U.S.)

·         Danaher Corporation (U.S.)

·         Exact Science Corporation (U.S.)

·         Epigenomics AG (Germany)

·         Biocept, Inc. (U.S.)

·         Pathway Genomics Corporation (U.S.)

·         Foundation Medicine, Inc. (U.S.)

·         Cancer Genetics, Inc. (U.S.)

 Notable Market Developments: Colorectal Cancer Diagnostics Market

·         In May 2015, EKF Diagnostics Holdings plc. has launched its next-generation sequencing technology Precision Path in partnership with Greenville Health Systems to test the colon cancer.

 Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/colorectal-cancer-diagnostics-market/#ulp-14mlyhjMGhVjZqa3

 Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/colorectal-cancer-diagnostics-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Clostridium difficile Infections Disease Pipeline Drugs Assessment: Clinical Trails Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018

Clostridium difficile Infections Disease Pipeline Drugs Assessment: Clinical Trails Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018

 Overview:

Clostridium difficile is a bacterium which infects the bowel and caused diarrhea. This infection is most commonly seen in people who were recently been treated with antibiotics and it can be spread easily to others. Clostridium difficile is also called as C. difficile or C.diff. C.diff infections may cause serious bowel problems. Symptoms of C.diff infections includes watery diarrhea, painful cramps in tummy, dehydration, dry mouth, head ache, loss of weight and appetite etc.

C.diff can be diagnosed by enzyme immunoassay, polymerase chain reaction, GDH or EIA. Treatment for Clostridium difficile infection includes antibiotics course.

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/clostridium-difficile-infectionsdisease-pipeline-drugs-assessment/#ulp-4H8Z4LpNMLEuOnnx

 Segmentation:

By Trial Phase, Clostridium difficile Infections pipeline drugs are segmented as:

·         Preclinical Trials

·         Phase 1

·         Phase 2

·         Phase 3

·         Phase 4

By Company, Clostridium difficile Infections pipeline drugs are segmented as:

·         Synthetic Biologics

·         Da Volterra

·         Pfizer Inc.

·         Valneva SE

·         Seres Therapeutics

·         Summit Therapeutics

·         Rebiotix Inc.

·         CRESTOVO

·         Merck

·         XBiotech

·         Others

By Drugs, Clostridium difficile Infections pipeline drugs are segmented as:

·         Vancomycin

·         Fidaxomicin

·         Metronidazole

·         Ridinilazole

·         Cadazolid

·         Bezlotoxumab

·         Others

��By Type of Condition Clostridium difficile Infections pipeline drugs are segmented as:

·         Systemic JIA

·         Oligoarthritis

·         Polyarticular arthritis,rheumatoid factor negative/ rheumatoid factor positive

·         Psoriatic arthritis

·         Enthesitis-related arthritis

·         Undifferentiated arthritis

By Route of Administration, Clostridium difficile Infections pipeline drugs are segmented as:

·         Oral

·         Parenteral

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/clostridium-difficile-infectionsdisease-pipeline-drugs-assessment/#ulp-c654SbFYO64MsOhu

  Space Analysis:

·         In July 2016, Valneva SE completed Phase II study for its prophylactic vaccine candidate VLA84 targeting primary prevention of difficile infection (CDI). The study met its primary endpoint in terms of identifying the dose/formulation with the highest seroconversion rate against both toxins A and B and confirmed the favorable safety profile observed in Phase

·         In June 2017, Seres Therapeutics, Inc. initiated Phase 3 clinical study of its SER-109 (ECOSPOR III) in patients with multiply recurrent difficile infection and also commenced Phase 1b clinical trial evaluating SER-262 in patients with primary Clostridium difficile infection (CDI).

·         On May 11, 2017 The U.S. Food and Drug Administration (FDA) granted a Breakthrough Therapy Designation for SYN-004 (ribaxamase) of Synthetic Biologicsfor the prevention of Clostridium difficile infection.

·         In October 2015, RBX2660 of Rebiotix was grated orphan drug status and fast track designation from U.S.FDA for its potential to prevent recurrent C. diff. infection.

 Report Description:

Clostridium difficile InfectionsDisease Pipeline Drugs Assessment report studies the various therapeutics under clinical development for Clostridium difficile Infections treatment along with targets for various drug candidate. The report provides plethora of information pertaining to trail phases, companies involved in the Clostridium difficile Infections disease pipeline drugs development. This report studies the dynamics of the Clostridium difficile Infections Disease Pipeline Drugs i.e. drivers, challenges and opportunities which are significantly impacting the product development. The report provides various information pertaining the clinical trials such as designation, grants, patents, and technology among others. Moreover, the report on Clostridium difficile Infections disease pipeline drugs assessment comprehensively presents the geographic location, trial status information along with key players involved in the therapeutics development.

 Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/clostridium-difficile-infectionsdisease-pipeline-drugs-assessment/#ulp-14mlyhjMGhVjZqa3

 Key Features of the Report:

·         Provides the information related to universities and research institutes working in the therapeutics development

·         Report comprehensively covers the all active and discontinued studies

·         Studies the entire pipeline with special emphasis on companies actively involved in the therapeutics development

·         Presents the prominent targets for drug development in each stage of clinical trial

·         Provides the in-depth analysis on the each drug candidates in the clinical trial phases

 Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/clostridium-difficile-infectionsdisease-pipeline-drugs-assessment/

About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Contact to Precision Business Insights,

 Kemp House,

152 – 160 City Road,

London EC1V 2NX

 Email: sales@precisionbusinessinsights.com

 Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Clinical Laboratory Services Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Market Outline: Clinical Laboratory Services Market

 Clinical laboratory services are very important part of the healthcare industry. These laboratories provide various services such as blood tests, diagnostic tests and genetic tests for the identifying the disease causes and play a major role in drug discovery process. Furthermore, clinical laboratory services provide information and offer services to improve the efficiency of healthcare systems such as diagnostic and test reports. The revolution of the genetic testing and biopharmaceuticals has led to the emergence of the new diagnostic procedures that involve laboratory testing

 Market Dynamics: Clinical Laboratory Services Market

 Clinical laboratory services market is mainly driven by the prevalence of the diseases such as cancer, infectious diseases and diabetes that require the clinical diagnosis of samples. In addition, growth in adaptation of clinical service outsourcing and aging population who are more susceptible to the diseases expected to boost the clinical laboratory services market over the forecast period. Furthermore, technological advancements that led to speeding up the testing and diagnosis and introduction of advanced products such as micro arrays and lab on chips are projected to bolster the market growth. The increase in demand for companion diagnostics also acting as driving factor for the market growth. However, lack of skilled professionals and stringent regulatory procedures may impend the clinical laboratory services market over the forecast period.

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/clinical-laboratory-services-market/#ulp-4H8Z4LpNMLEuOnnx

   Market Scope: Clinical Laboratory Services Market

 Global clinical laboratory services market is segmented based on test type, service provider, and application

 Based on test type, clinical laboratory services market is segmented into

 ·         Clinical Chemistry

·         Medical Cytology & Microbiology

·         Human & Tumor Genetics

 Based on service provider, clinical laboratory services market is segmented into

 ·         Hospitals Based

·         Standalone Laboratories

·         Clinical Laboratories

 Based on application, clinical laboratory services market is segmented into

 ·         Gene Therapy

·         Toxicological Study

·         Drug Discovery and Development

·         Pre-clinical & Clinical Trial Services

·         Others

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/clinical-laboratory-services-market/#ulp-c654SbFYO64MsOhu

  Market overview: Clinical Laboratory Services Market

 Global laboratory services market is expected to grow at significant rates owing to technological advancements in the laboratory technologies. For instance, microarrays and lab on chips are the revolutionary products that enabled the preparation of DNA and RNA or protein samples which can be analyzed in a single chip. The market is highly competitive due to the presence of more number of market players present internationally and regionally. Companies in the market are acquiring other market players to expand their geographical reach and further increase their market share. For instance, in October 2017, Abbot Laboratories acquired Alere Inc., a leader in point of care diagnostics and clinical laboratory services provider to strengthen its product portfolio. Similarly, in may 2017, LabCorp, has acquired Pathology Associates Medical Laboratories (PAML), a premier medial reverence laboratory and healthcare solution company of Washington, to expand its geographic presence.

  Region Overview: Clinical Laboratory Services Market

 Geographically, clinical laboratory services market is segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America clinical laboratory services market is expected to grow at significant rates owing to the factors such as growing research and development in biotechnological field that requires clinical testing and presence and well-established healthcare infrastructure and growing prevalence of the diseases such as cardiovascular diseases, cancer, and infectious diseases. Asia Pacific region is expected to have significant growth rate owing to the factors such as developing healthcare infrastructure and increase in funding for R&D in the field of healthcare for developing new drugs and diagnosis of diseases. Europe clinical laboratory services market is expected to grow at notable rates owing to the presence of many local and multinational players who are actively involving in acquisitions and mergers to increase their market share. Furthermore, growing aging population in this region who are susceptible to the diseases may drive the market growth.

 Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/clinical-laboratory-services-market/#ulp-14mlyhjMGhVjZqa3

  Competition Assessment: Clinical Laboratory Services Market

 Some of the players in clinical laboratory services market are Bio-Reference Laboratories Inc. (OPKO Health) (U.S.), Alere, Inc. (Abbott Laboratories) (U.S.), DaVita Healthcare Partners, Inc. U.S.), Laboratory Corporation of America Holdings (U.S.), Genomic Health, Inc. (U.S.), Myriad Genetics, Inc. (U.S.), Quest Diagnostics, Inc. (U.S.), NeoGenomics, Inc. (U.S.), Siemens Healthineers (Siemens AG) (Germany), Spectra Laboratories (Fresenius Medical) (Germany), SYNLAB Group (Germany), and Sonic Healthcare Limited (Australia).

 Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/clinical-laboratory-services-market/

[coolvoidunknown-blog]

Circulating Tumor Cell (CTC) Testing Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Global Circulating Tumor Cell (CTC) Testing Market: Technology (CTC detection (Functional in-vitro cell invasion assay, Molecular(RNA) based technologies, Xenotransplantation models, Immunocytochemical technologies, EPISPOT functional in-vitro cell culture), (CTC Enrichment (Microchips, In-vivo positive selection, Single spiral micro channel, Ex-vivo positive selection, Negative selection), CTC Analysis), Application (EMT biomarkers development, Cancer stem cell research, Tumorigenesis research, Others), End user (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers) and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 Global Circulating Tumor Cell (CTC) Testing market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024.

 Market Outline: Circulating Tumor Cell (CTC) Testing Market

Circulating Tumor Cell (CTC) Testing is a simple blood test which helps oncologists to assess the prognosis of patients with metastatic colorectal, breast or prostate cancer. The cell search test is the only FDA approved test for CTC assessment. CTC’s are the cancer cells that detach from solid tumors and enter the blood stream.

 Market Dynamics: Circulating Tumor Cell (CTC) Testing Market

Increasing in number of cancer cases and rise in geriatric population are the major factors which are attributing for the growth of the circulating tumor cell (CTC) testing market globally. As per the WHO statistics cancer accounts for 13% of deaths globally every year, moreover 70% increase in cancer incidences is anticipated over the next couple of decades and global geriatric population is anticipated to nearly double from 12% to 22% from 2015 to 2022. Furthermore, advanced technologies in circulating tumor cell (CTC) testing, improved healthcare expenditure, growing awareness regarding circulating tumor cell (CTC) testing and increased government support are the few more factors which are boosting the growth of circulating tumor cell (CTC) testing market globally. However, stringent regulatory framework, prolonged time of approvals for product launching and cost containment measures are the few factors restraining the growth of circulating tumor cell (CTC) testing market globally.

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/circulating-tumor-cell-ctc-testing-market/#ulp-4H8Z4LpNMLEuOnnx

  Market Scope: Circulating Tumor Cell (CTC) Testing Market

Circulating Tumor Cell (CTC) Testing market is segmented based on the technology, application, end user and geographical regions

Based on the Technology, the market is segmented into the following:

·         CTC Detection

o    Functional in-vitro cell invasion assay

o    Molecular(RNA) based technologies

o    Xenotransplantation models

o    Immunocytochemical technologies

o    EPISPOT functional in-vitro cell culture

·         CTC Enrichment

o    Microchips

o    In-vivo positive selection

o    Single spiral micro channel

o    Ex-vivo positive selection

o    Negative selection

·         CTC Analysis

Based on the Application, the market is segmented into the following:

·         EMT biomarkers development

·         Cancer stem cell research

·         Tumorigenesis research

·         Others

Based on the end user, the market is segmented into the following:

·         Diagnostic Centers

·         Hospitals

·         Ambulatory Surgical Centers

Based on the geographical regions, the market is segmented into the following:

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         The Middle East and Africa

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/circulating-tumor-cell-ctc-testing-market/#ulp-c654SbFYO64MsOhu

  Market Summary: Circulating Tumor Cell (CTC) Testing Market

Global Circulating Tumor Cell (CTC) testing market is highly fragmented with small biotech firms holding a chunk of the overall industry share. CTC are very rare that an average only 1 CTC is present in 1 billion blood cells and CTC clusters are even rarer. Recent development of cluster chip has been successful in capturing CTC clusters ranging between 2-17 cells is an important development in the global market. According to WHO, cancer incidence is projected to rise by 50% to reach 15 million by the end of this decade. This alarming increase in a number of patients necessitates this as a potential treatment approach addressing the growing global burden of the disease. Biotech firms dominate the global circulating tumor cell (CTC) testing market. The players are constantly engaged in R&D in order to develop novel methods to treat cancers. Favorable government initiatives will fuel global circulating tumor cell (CTC) testing market size. For instance, CDC supports nationwide screening programs for control of breast, cervical and colorectal cancer among low-income women with little or no health insurance.

 Regional Analysis:  Circulating Tumor Cell (CTC) Testing Market

Geographically, global Circulating Tumor Cell (CTC) testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America dominates the global market for circulating tumor cell (CTC) testing market due to a large number of aging population and technological advancement in the region, heavy investments in R & D activities along with government support will boost the industry demand over the coming years. The UK market is anticipated to grow rapidly over the forecast timeline due to the rising occurrence of cancer along with increasing acceptance of advanced technology. Asia is expected to witness high growth in circulating tumor cell (CTC) testing market, due to increasing government initiatives, rising economy, and improvement in healthcare infrastructure in the region. Some of the key driving forces for circulating tumor cell (CTC) testing market in emerging countries are increasing R&D investment, a large pool of patients and rising government funding.

 Competition Assessment: Circulating Tumor Cell (CTC) Testing Market

Some of the players in the global Circulating Tumor Cell (CTC) Testing market include:

·         Fluxion Biosciences (U.S.),

·         Clearbridge BioMedics (Singapore)

·         Adnagen (Germany), Apocell (U.S.)

·         Advanced Cell Diagnostics (U.S.)

·         Cynvenio Biosystems (U.S.)

·         Aviva Biosciences (U.S.)

·         Biocept Inc. (U.S.)

·         Canopus Biosciences (U.S.)

·         Biofluidica (U.S.)

 Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/circulating-tumor-cell-ctc-testing-market/#ulp-14mlyhjMGhVjZqa3

  Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/circulating-tumor-cell-ctc-testing-market/

 About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Contact to Precision Business Insights,

 Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Chlamydia Infection Diagnostics and Therapeutics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

 Market Outline: Chlamydia Infection Diagnostics and Therapeutics Market

 Chlamydia is a sexually transmitted disease (STD) caused by the bacteria Chlamydia trachomatis, and it can be transmitted to baby at birth. Chlamydia infection usually doesn’t have any symptoms but often infected may have symptoms such as genital pain and genital discharge both in men and women. Furthermore, chlamydia infection can cause health complications such as preventing women from getting pregnant or even endangering their pregnancies. Some people may experience pain in lower abdomen, pelvis, testicle or vagina and may also have eye discharge or spotting. Treatment may include antibiotics, anti-inflammatory agents, and hospital stay may be required.

  Market Dynamics: Chlamydia Infection Diagnostics and Therapeutics Market

 Global chlamydia infection diagnostics and therapeutics market is mainly driven by increase in prevalence of sexually transmitted diseases worldwide. Furthermore, emergence of rapid test and advances in biotechnology are expected to boost the chlamydia infection diagnostics and therapeutics market. In addition, increase in R&D activities towards development of therapeutics for antibiotic-resistant bacteria and initiatives by government and non-government agencies (such as World Health Organization (WHO) to increase awareness about STD’s and their symptoms are expected to bolster the chlamydia diagnostics and therapeutics market during the forecast period. However, high cost of development, stringent regulatory procedures for the approval and bacterial drug resistance is expected to hamper the chlamydia infection diagnostics and therapeutics market.

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/chlamydia-infection-diagnostics-and-therapeutics-market/#ulp-4H8Z4LpNMLEuOnnx

   Market Scope: Chlamydia Infection Diagnostics and Therapeutics Market

 Global chlamydia infection diagnostics and therapeutics market is segmented into diagnostics, therapeutics type, and end user type

  Based on diagnostics, market is segmented into

 ·         Direct Fluorescent Tests

·         Nucleic Acid Amplification Tests

·         Others

 Based on therapeutics, market is segmented into

 ·         Antibiotics

o    Tetracyclines

o    Macrolides

o    Quinolones

o    Others

·         Others

 Based on end user, market is segmented into

 ·         Hospitals and Hospital Pharmacies

·         Retail Pharmacies

·         Others

 Based on geography, market is segmented into

·         North America

·         Asia Pacific

·         Europe

·         Middle East and Africa

·         Latin America

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/chlamydia-infection-diagnostics-and-therapeutics-market/#ulp-c654SbFYO64MsOhu

  Market overview: Chlamydia Infection Diagnostics and Therapeutics Market

  Global chlamydia infection diagnostics and therapeutics market is growing at significant rates owing to prevalence rate of sexually transmitted diseases. According to World Health Organization (WHO), worldwide, more than one million sexually transmitted infections are acquired every day. Each year, an estimate of 131 million new cases of chlamydia infection are reported. Companies are focusing on the development of the new ways to detect chlamydia infection in initial stages. For instance, in December 2016,  F. Hoffmann-La Roche AG launched cobas 6800/8800 systems for detection of Chlamydia trachomatis and Neisseria Gonorrhoea (NG) DNA.

  Region Overview: Chlamydia Infection Diagnostics and Therapeutics Market

 Geographically, chlamydia infection diagnostics and therapeutics market is segmented into Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America market is expected to grow at significant rates owing to well-established healthcare infrastructure, presence of more number of market players and increase in awareness in related to early detection and treatment of sexually transmitted diseases. According to Centre for Disease Control and Prevention (CDC) in 2014, a total number of 1,441,789 chlamydia infections were reported to CDC in 50 states and District of Columbia in the United States. Europe chlamydia infection diagnostics and therapeutics market is expected to grow at notable rates owing to factors such as developed healthcare infrastructure and growing awareness related to STI’s. Asia Pacific market growth is attributed to developing infrastructure and prevalence of the chlamydia sexually transmitted diseases. According to World Health Organization, “Global incidence and prevalence of selected curable sexually transmitted infections – 2008”, in South East Asia region estimated that 8 million adults were infected with Chlamydia in 2008.

 Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/chlamydia-infection-diagnostics-and-therapeutics-market/#ulp-14mlyhjMGhVjZqa3

   Competition Assessment: Chlamydia Infection Diagnostics and Therapeutics Market

 Some of the players in chlamydia infection diagnostics and therapeutics market are Novartis AG (Switzerland), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), The Danaher Corporation (U.S.), Abbott Laboratories (U.S.), bioMérieux (France), Siemens AG (Germany), DiaSorin SpA (Italy), Becton Dickinson and Company (U.S.), and Thermo Fisher Scientific (U.S.)

 Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/chlamydia-infection-diagnostics-and-therapeutics-market/

[coolvoidunknown-blog]

China Facial Aesthetics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

China facial aesthetics market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 and 2024

 Market Outline: China Facial Aesthetics Market

China facial aesthetics are the new luxury bag for many people in urban China. In the recent decades, China’s aesthetics market has shown a rapid growth. Facial aesthetics are usually used to soften expression lines and define facial contours. There are various types of injections or injectable fillers that can enhance the natural beauty and rejuvenates the skin. Facial aesthetics gives a radiant glow to the skin.

 Market Dynamics: China Facial Aesthetics Market

Increasing beauty conscious is major cause for the growth of the facial aesthetics in the China. The rising awareness among the people about the advanced cosmetic treatments is also enriching the growth of the china facial aesthetic market. The rising adoption of the invasive and non-invasive procedures is also influencing the growth of the market. The easy treatment options are attracting people towards the facial aesthetics. The growing cosmetic clinics are driving the market growth. However, the higher cost involved in the treatment procedures and low focus on the R&D activities are likely to hamper the growth of the china facial aesthetics market.

  A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/china-facial-aesthetics-market/#ulp-4H8Z4LpNMLEuOnnx

 Market Scope: China Facial Aesthetics Market

China facial aesthetics market is segmented based on the technology, products, and distribution channel

Based on the technology, the market is segmented into the following:

·         Laser-Based Technology

·         Energy-Based Technology

Based on the products, the market is segmented into the following:

·         Aesthetic Implants

o    Chin implants

o    Jaw Implants

o    Others

·         Aesthetic Lasers and Energy Devices

o    Laser Resurfacing Devices

o    Body Contouring Devices

Based on the distribution channel, the market is segmented into the following:

·         Dermatology Clinics

·         Medical Spa’s

·         Others

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/china-facial-aesthetics-market/#ulp-c654SbFYO64MsOhu 

 Competition Assessment: China Facial Aesthetics Market

Some of the players in the china facial aesthetics market include:

·         Cynosure, Inc.

·         Allergan, Inc.

·         Lumenis Ltd

·         Solta Medical, Inc.

·         ZELTIQ Aesthetics, Inc.

 Notable Market Developments: China Facial Aesthetics Market

·         In December 2016, Cynosure received China FDA clearance for Icon Aesthetic System

   Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/china-facial-aesthetics-market/#ulp-14mlyhjMGhVjZqa3

 Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides a plethora of information about market entry strategies and regulatory framework

·         The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/china-facial-aesthetics-market/

About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Contact to Precision Business Insights,

 Kemp House,

152 – 160 City Road,

London EC1V 2NX

 Email: sales@precisionbusinessinsights.com

 Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Cervical Ripening Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Market Outline: Cervical Ripening Drugs Market

Cervical ripening is defined as the softening of cervix prior to onset of labor contractions and it is necessary for the cervical dilation and passage of fetus. Cervix softens, thins, dilates, and relaxes in response to the uterine contractions and allows the cervix to easily pass over the fetal part during labor. Cervical ripening Drugs are used before the induction of labor for the dilatation of cervix. The ripening of cervix is associated with the reduced collagen fiber strength, decrease in collagen fiber alignment, and diminished the tensile strength of extracellular cervical matrix. The common techniques used for the cervical ripening are mechanical interventions such as insertion of cervical catheters and dilators and application of cervical ripening agents such as prostaglandins.

 Market Dynamics: Cervical Ripening Drugs Market

Growing usage of cervical ripening Drugs before the induction of labor, rise in R&D activities for the innovation of newer Drugs, increase in awareness about cervical ripening Drugs in developed and developing countries, low cost of Drugs, and government initiations for improving the baby deliveries are anticipated to fuel the cervical ripening Drugs market over the forecast period. However, stringent regulatory policies for product approval, adverse effects associated with the cervical ripening Drugs, and alternative procedures for the childbirth are expected to hinder the growth of surgical ripening Drugs market over the forecast timeframe.

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/cervical-ripening-drugs-market/#ulp-4H8Z4LpNMLEuOnnx

  Market Scope: Cervical Ripening Drugs Market

Cervical ripening Drugs market is segmented on the basis of drug type, route of administration, distribution channel, and region

Based on the drug type, market is segmented into the following:

·         Prostaglandins

·         Oxytocin

·         Progesterone Receptor Antagonists

·         Relaxin

·         Estrogen

·         Others

Based on the route of administration, market is segmented into the following:

·         Oral

·         Intravenous

·         Vaginal

Based on the distribution channel, market is segmented into the following:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Others

  To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/cervical-ripening-drugs-market/#ulp-c654SbFYO64MsOhu

  Market Summary: Cervical Ripening Drugs Market

Cervical ripening Drugs market is projected to grow at a significant rate with increase in the usage of cervical ripening Drugs prior to the induction of labor. Moreover, acquisitions and mergers, product approvals, and product launchings are the key strategies adopted by market players to generate increased revenue in cervical ripening Drugs market. For instance, in February 2012, Ferring Pharmaceuticals acquired Cytokine PharmaSciences Inc. and the acquisition includes manufacturing assets of Cervidil (Dinoprostone) in U.S. and Canada.

 Regional Analysis:  Cervical Ripening Drugs Market

Geographically, global cervical ripening Drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America cervical ripening Drugs market growth driven by increase in the R&D for the innovation of newer Drugs and high awareness about the cervical ripening Drugs among the physicians. Europe cervical ripening Drugs market has a lucrative growth owing to high adoption of cervical ripening Drugs, launching of newer Drugs by the market players. Asia Pacific cervical ripening Drugs market has significant share owing to rise in number of female population, government initiations for the baby birth, and increase in the using of cervical ripening Drugs before the induction of labor are propel the market. Middle East and Africa cervical ripening Drugs market has a prominent share owing to increase in the number of births and rise in awareness about the cervical ripening Drugs are in the region.

 Competition Assessment: Cervical Ripening Drugs Market  

Some of the players in the global cervical ripening Drugs market include:

·         Ferring B.V. (Switzerland)

·         Azanta A/S (Denmark)

·         Novartis AG (Switzerland)

·         GlaxoSmithKline plc (U.K.)

·         AstraZeneca plc (U.K.)

·         Pfizer, Inc. (U.S.)

·         Bayer AG (Germany)

 Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/cervical-ripening-drugs-market/#ulp-14mlyhjMGhVjZqa3

  Notable Market Developments: Cervical Ripening Drugs Market

·         In February 2016, Azanta A/S filed marketing authorization application in Nordic countries for Angusta (Misoprostol), which is indicated in induction of labor

 Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012 to 2016) and forecast (2017 to 2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

  Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/cervical-ripening-drugs-market/

 About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 Contact to Precision Business Insights,

 Kemp House,

 152 – 160 City Road,

 London EC1V 2NX

 Email: sales@precisionbusinessinsights.com

 Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Center Pivot Irrigation Systems Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

The Global Center Pivot Irrigation Systems Market: By Crop Type (Fruits and Vegetable, Cereals and Grains, Pulses and Oilseeds, Turf and Ornamental, Flowers and Others), By Size of the Field (Large, Medium, Small), By Components (Pivot Points, Control Panels, Span, Sprinkler Drop, Drive Train, Tower Drive Wheels), By Motion (Mobile, Immobile), By Geography (Latin America, North America, Asia- Pacific, the Middle East & Africa and Europe) – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

 Market Outline: Global Center Pivot Irrigation Systems Market  

 Center pivot irrigation is known as central pivot irrigation or circle irrigation or waterwheel irrigation. Center pivot irrigation method is crop irrigation method in which an equipment is rotated around the pivot by watering the crops with the help of sprinklers. Earlier, most of the center pivot systems are water powered while currently most of them are propelled by electric motors. Center pivot irrigation system was invented by Farmer Frank Zybach from Colorado in 1940. Center pivot irrigation system was recognized as most preferable method of enhancing distribution of water to the whole crop in the fields.

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/center-pivot-irrigation-systems-market/#ulp-4H8Z4LpNMLEuOnnx

 Market Dynamics: Global Center Pivot Irrigation Systems Market  

 Drivers of global center pivot irrigation systems market

 ·         Efficiency of water management

·         Increase in demand for high quality of crops

·         Less wastage of water

·         Large returns of investments in comparison with conventional irrigation systems

·         Increase in government subsidies and initiatives

 Restraints of global center pivot irrigation systems market

 ·         High cost associated with initial setup

·         Difficulty in maintenance

·         Lack of awareness

 Market Scope: Global Center Pivot Irrigation Systems Market  

 The global center pivot irrigation systems market is classified on the basis crop type, size of the field, components, motion and regions

 Based on crop type, global center pivot irrigation systems market is segmented as

·         Fruits and Vegetable

·         Cereals and Grains

·         Pulses and Oilseeds

·         Turf and Ornamental

·         Flowers and Others

 Based on size of the field, global center pivot irrigation systems market is segmented as

·         Large

·         Medium

·         Small

 Based on components, global center pivot irrigation systems market is segmented as

·         Pivot Points

·         Control Panels

·         Span

·         Sprinkler Drop

·         Drive Train

·         Tower Drive Wheels

 Based on motion, global center pivot irrigation systems market is segmented as

·         Mobile

·         Immobile

 Based on region, global center pivot irrigation systems market is segmented as

·         North America

·         Latin America

·         Europe

·         Asia Pacific

·         The Middle East and Africa

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/center-pivot-irrigation-systems-market/#ulp-c654SbFYO64MsOhu

 Competition Assessment: Global Center Pivot Irrigation Systems Market

 Some of the players in global center pivot irrigation systems market are

·         Valmont Industries, Incorporated (U.S.)

·         Lindsay Corporation (U.S.)

·         Alkhorayef Group (Saudi Arabia)

·         Grupo Fockink (Brazil)

·         T-L Irrigation Company (U.S.)

·         Rainfine (Dalian) Irrigation Co., Ltd. (China)

·         Reinke Manufacturing Co, Inc. (U.S.)

·         BAUER GmbH (Austria)

  Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/center-pivot-irrigation-systems-market/#ulp-14mlyhjMGhVjZqa3

  Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

   Get access to full summary @

 https://www.precisionbusinessinsights.com/market-reports/center-pivot-irrigation-systems-market/

 About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Contact to Precision Business Insights,

 Kemp House,

152 – 160 City Road,

London EC1V 2NX

 Email: sales@precisionbusinessinsights.com

 Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Celiac Disease Pipeline Drugs Assessment: Clinical Trails Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018

Celiac Disease Pipeline Drugs Assessment: Clinical Trails Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018

 Celiac Disease Pipeline Drugs Assessment

 Overview:

Celiac Diseaseis a genetic autoimmune disease. It is caused due to the consumption of protein called gluten, which is found in barley, wheat,and rye. It enables damage the finger-like villi of small intestine and body will be unable to absorb nutrients into thebloodstream that leads to malnutrition. Symptoms of celiac disease include food allergy, watery and itchy eyes, difficulty in breathing, nausea, abdominal pain, mouth ulcers.

Celiac disease is diagnosed by serology tests and genetic tests. Treatment includes strict gluten-free diet. There are no FDA approved drugs to treat celiac disease.

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/celiac-disease-pipeline-drugs-assessment/#ulp-4H8Z4LpNMLEuOnnx

 Segmentation:

By Drugs, Celiac Disease pipeline drugs are segmented as:

·         Larazotide

·         Pancrelipase

·         Rifaximin

·         Triamcinolone

·         Bupivacaine

By Route of Administration, Celiac Disease pipeline drugs are segmented as:

·         Oral

·         Parenteral

By Trial Phase, Celiac Diseasepipeline drugs are segmented as:

·         Preclinical

·         Phase 1

·         Phase 2

·         Phase 3

·         Phase 4

By Company, Celiac Diseasepipeline drugs are segmented as:

·         AMYRA Biotech AG (Switzerland)

·         Avaxia Biologics, Inc. (U.S.)

·         Calypso Biotech SA (Switzerland)

·         Provid Pharmaceuticals Inc. (U.S.)

·         Sitari Pharmaceuticals (U.S.)

·         Cour Pharmaceuticals (U.S.)

·         Glenmark Pharmaceuticals Ltd. (India)

·         Innovate Biopharmaceuticals (U.S.)

·         Others

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/celiac-disease-pipeline-drugs-assessment/#ulp-c654SbFYO64MsOhu

   Space Analysis:

·         In November 2017, ImmusanT, Inc.raised $40 million Series C equity financing from ARCH Venture Partners and Vatera Healthcare Partners to proceedPhase II clinical trial of escalating doses of Nexvax2 in celiac patients who possess the human leukocyte antigen DQ2.5 (HLA-DQ2.5) immune recognition gene.

·         In February 2016, Innovate Biopharmaceuticals Inc., completed an agreement to license Alba Therapeutics assets relating to larazotide acetate, a tight junction regulator, progressing toward Phase 3 clinical trials for the treatment of celiac disease.

·         In December 2015, Takeda Pharmaceutical Company Limited and Cour Pharmaceutical Development Company, Inc. entered into a partnership to research and develop novel immune modulating therapies for the potential treatment of celiac disease

·         In March 2015, Falk Pharma and Zedira entered into a collaboration to perform Phase 1 clinical trials of ED1227, a direct-acting inhibitor of tissue transglutaminase. The small molecule targets the dysregulated transglutaminase within the small intestine in order to dampen the immune response to gluten which drives the celiac disease process.

 Report Description:

Celiac Disease Pipeline Drugs Assessment report studies the various therapeutics under clinical development for Celiac Disease treatment along with targets for various drug candidate. The report provides plethora of information pertaining to trail phases, companies involved in the Celiac Disease pipeline drugs development. This report studies the dynamics of the Celiac Disease Pipeline Drugs i.e. drivers, challenges and opportunities which are significantly impacting the product development. The report provides various information pertaining the clinical trials such as designation, grants, patents, and technology among others. Moreover, the report on Celiac Disease pipeline drugs assessment comprehensively presents the geographic location, trial status information along with key players involved in the therapeutics development.

 Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/celiac-disease-pipeline-drugs-assessment/#ulp-14mlyhjMGhVjZqa3

   Key Features of the Report:

·         Provides the information related to universities and research institutes working in the therapeutics development

·         Report comprehensively covers the all active and discontinued studies

·         Studies the entire pipeline with special emphasis on companies actively involved in the therapeutics development

·         Presents the prominent targets for drug development in each stage of clinical trial

·         Provides the in-depth analysis on each drug candidates in the clinical trial phases

  Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/celiac-disease-pipeline-drugs-assessment/

About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Contact to Precision Business Insights,

 Kemp House,

152 – 160 City Road,

London EC1V 2NX

 Email: sales@precisionbusinessinsights.com

 Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Carotenoids Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Global Carotenoids Market: By Source (Natural, Synthetic), By Technology (Manually Operated Inhalers, Digitally Operated Inhalers), By Type (Beta-carotene, Astaxanthin, Canthaxanthin, Zeaxanthin, Lutein, Lycopene, Annatto, Others), By Applications (Food & Beverages, Animal Feed, Pharmaceuticals, Cosmetics, Dietary Supplements), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 Global carotenoids market was valued at US $ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 and 2024

 Market Outline: Carotenoids Market

Carotenoids are the organic pigments, which are also called as the tetraterpenoids. Carotenoids belong to the class of phytonutrients. They are generally produced by the plants and algae, various bacteria and fungi and in some species of animals such as aphids and spider mites. The carotenoids are responsible for the red, yellow and orange hues in various fruits and vegetables. Carotenoids have the anti-inflammatory properties which help in the improvement of the immune system and also has the capability of preventing cardiovascular diseases. Carotenoids also have the cancer-fighting properties. Carotenoids act as the antioxidants and present in various fruits and vegetables such as mangoes, oranges, papaya, spinach, tomatoes, bell peppers and many others.

 Market Dynamics: Carotenoids Market

Increase in the prevalence of chronic conditions such as eye disorders, cancer and diabetes are the key factors anticipating the drive the growth of the carotenoids market. The growing health disorders such as nutrition deficiency and obesity and increasing health concerns are likely to drive the growth of the carotenoids market. The antioxidant property of the carotenoids is helpful in both the pharmaceutical industry as well as the cosmetic industry which is boosting the growth of the market. The higher cost involved in the production and the low yield of the carotenoid is likely to hamper the growth of the carotenoids market.

  A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/carotenoids-market/#ulp-4H8Z4LpNMLEuOnnx

 Market Scope: Carotenoids Market

Carotenoids market is segmented based on the source, type, and application.

Based on the source, the market is segmented into the following:

·         Natural

·         Synthetic

Based on the type, the market is segmented into the following:

·         Beta-carotene

·         Astaxanthin

·         Canthaxanthin

·         Zeaxanthin

·         Lutein

·         Lycopene

·         Annatto

·         Others

Based on the application, the market is segmented into the following:

·         Food & Beverages

·         Animal Feed

·         Pharmaceuticals

·         Cosmetics

·         Dietary Supplements

  To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/carotenoids-market/#ulp-c654SbFYO64MsOhu

 Regional Analysis:  Carotenoids Market

Geographically, global carotenoids market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America carotenoids market is dominant when compared with other regional markets. The changing lifestyles is majorly influencing the growth of the market. The growing health consciousness and owing to its use in the cosmetic industry, the carotenoids are gaining popularity in this region. Following North America are the regions of Europe and Asia Pacific. The Asia Pacific region is expected to grow at significant rate over the forecast period due its technological advancements and the economic growth. The presence of major players in this region is also adding fuel to the growth of the carotenoids market in the region.

 Competition Assessment: Carotenoids Market

Some of the players in the global carotenoids market include:

·         D. Williamson (U.S)

·         DSM Nutritional Products (Netherlands)

·         Allied Biotech (Taiwan)

·         Naturex SA (France)

·         Kemin Industries (U.S)

·         Brenntag (Germany)

·         ExcelVite Sdn. Bhd (Malaysia)

·         Cyanotech Corp (U.S)

 Notable Market Developments: Carotenoids Market

·         In February 2018, KnipBio has developed SCP strain to produce astaxanthin for aqua feed.

 Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/carotenoids-market/#ulp-14mlyhjMGhVjZqa3

 Key Features of the Report:

·         The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)

·         The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

  Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/carotenoids-market/

About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Contact to Precision Business Insights,

 Kemp House,

152 – 160 City Road,

London EC1V 2NX

 Email: sales@precisionbusinessinsights.com

 Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Cardiac Assist Devices: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

 Market Outline: Cardiac Assist Devices Market

 Cardiac assist devices are mechanical pumps, which are used to support or replace the blood flow in weak cardiac function people and patients with heart failure. These are implantable devices and can be used temporarily to help the heart rate and blood flow.

 Market Dynamics: Cardiac Assist Devices Market

 Rising prevalence of cardiac disorders, surge in geriatric population and technological developments in cardiac assist devices, which minimize the chances of infection and improved efficiency enables attract demand for cardiac assist devices. In addition, rising number of cases of heart failure and shortage of donors for late stage heart failure patients expected to boost the market during the forecast period. However, factors such as availability of alternative treatment options such as pace makers and heart transplantation expected to hinder the market growth. Furthermore chances of infection, high cost of devices and stringent regulatory procedures expected to act as restraints for the growth of the market over the forecast period.

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/cardiac-assist-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 Market Scope: Cardiac Assist Devices Market

Global cardiac assist devices are segmented based on type of product, flow rate and end user

Based on the type of product, it is segmented into

·         Ventricular Assist Devices (VDS)

o    External Ventricular Assist Devices

o    Left Ventricular Assist Devices (LVDS)

o    Biventricular Assist Devices

o    Right Ventricular Assist Devices

·         Intra-Aortic Balloon Pumps

·         Total Artificial Heart

Based on flow rate, it is segmented into

·         Continuous Flow

·         Pulsatile

Based on end user, it is segmented into

·         Hospitals

·         Ambulatory Surgical Centres

·         Others

   To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/cardiac-assist-devices-market/#ulp-c654SbFYO64MsOhu

  Market overview:  Cardiac Assist Devices Market

 Global cardiac assist devices is expected to grow at significant rate owing to increase in cases heart failure around the world. Cardiac assist devices are one of promising treatment option for heart failure patients. Market players are focused on vertical integration in order to develop innovative products. For instance, in October 2013, Sunshine Heart Inc. (changed name to CHF Solutions Inc.) collaborated with Minnetronix Inc. to develop transcutaneous energy transfer system to power the companies fully- implantable C-Pulse heart assist system. For instance Medtronic Plc. has expanded its product portfolio in cardiac assist devices market by the acquisition of HeartWare International, Inc. in June 2016. Similarly in October 2015, St. Jude Medical, Inc. (acquired by Abbott Laboratories) acquired Thoratec Corporation to strengthen their heart failure market portfolio.

 Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/cardiac-assist-devices-market/#ulp-14mlyhjMGhVjZqa3

  Region Overview: Global Cardiac Assist Devices Market

 Global cardiac assist devices is segmented into following regions, viz. North America, Asia-Pacific, Latin America, Middle East & Africa, and Europe. North America is expected to be major market for cardiac assist devices owing to factors such as growing awareness in patients about the cardiac assist devices, well established healthcare infrastructure and favourable reimbursement policies. Europe cardiac assist devices market expected to grow at significant rates owing to increase in growing heart related diseases and rising geriatric population. Asia-Pacific expected to grow at notable rates owing to developing healthcare infrastructure and growing awareness in patients.

 Competition Assessment: Cardiac Assist Devices Market

 Some of the players in global Cardiac Assist Devices are Calon Cardio-Technology Ltd. (UK) SynCardia Systems, Inc. (U.S.), Medtronic (U.S.), Berlin Heart GmbH (Germany), CHF Solutions, Inc. (U.S.), Teleflex Incorporated (U.S.), MAQUET GmbH & Co. (Germany), Abiomed (U.S.) and Abbot Laboratories (U.S.).

 Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/cardiac-assist-devices-market/

 About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Capnography Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

 Market Outline: Capnography Devices Market

Capnography is the process of monitoring partial pressure or concentration of carbon dioxide in respiratory gases by using capnogram. It is majorly used as a monitoring tool during intensive care and anesthesia. Capnography helps to anesthesiologists to prevent the hypoxia and help to determine the situations that can lead to hypoxia and may cause irreversible brain damage. Due to these advantages, capnography is widely used in endoscopic suites, emergency rooms, x-ray rooms, and on-site emergency and trauma centres. In healthy individuals, the difference between the arterial blood and expired CO2 partial pressure is very small, however, in presence of lung disease, and some congenital heart disease the difference is increased and can exceed 1 kPa.

 Market Dynamics: Capnography Devices Market

Increase in the prevalence of respiratory diseases such as COPD, pulmonary embolism, bronchospastic diseases and asthma (according to World Health Organization, approximately more than 3 Mn people die each year with COPD around the globe), technological advancements in the capnography devices, and recommendation by American Heart Association (AHA) and The American Society of Anesthesiologists (ASA) are anticipated to fuel the capnography devices market. Moreover, the wide range of applications of capnography devices in hypoventilation, esophageal intubation, and endotracheal tube placement, growing geriatric population, minimally invasive nature, and ease of use are expected to propel the capnography devices market over the forecast period. However, alternative devices availability for capnography such as pulse oximeter, new clinical studies restraining the usage in non-intubated individuals, and issues associated with capnography usage are impeding the growth of capnography devices market.

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/capnography-devices-market/#ulp-4H8Z4LpNMLEuOnnx

   Market Scope: Capnography Devices Market

Capnography devises market is segmented on the basis of product type, technology, application, and end user

Based on product type, the market is segmented into the following:

·         Capnographs

o    Micro-Stream Capnographs

o    Side-Stream Capnographs

o    Main Stream Capnographs

·         Disposables

Based on technology, the market is segmented into the following:

·         Hand-Held Monitors

·         Stand-Alone Monitors

·         Others

Based on application, the market is segmented into the following:

·         Anesthesia

·         Procedural Sedation

·         Intensive Care

·         Pain Management

·         Emergency Medicine

·         Others

Based on end user, the market is segmented into the following:

·         Hospitals

·         Clinics

·         Ambulatory Surgical Centers

  To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/capnography-devices-market/#ulp-c654SbFYO64MsOhu

  Market Summary: Capnography Devices Market

Capnography devises market growing at a significant rate due to the implementation of regulatory guidelines for procedural sedation and rise in adoption of capnography devices due to higher efficiency and reliability are anticipated to fuel the capnography devices market. Moreover, technological advancements in capnography devices, such as Oridion’s micro-stream technology helps in reducing the dispersion of gases in sampling tube and increase in the prevalence of asthma (according to WHO 2013, approximately 235 Mn people suffered from asthma) expected to drive the market. Furthermore, acquisitions and mergers, product approvals, and product launchings are the strategies followed by the market players for increasing their revenue in capnography devices market. For instance, in October 2013, Covidien, a subsidiary of Medtronic plc launched Capnostream 20p bedside monitor with Covidien’s micro-stream technology. Moreover, in July 2013, Masimo launched Emma capnograph with waveform display, helps to determine the end-tidal carbon dioxide and respiration rate.

 Regional Analysis: Capnography Devices Market

Geographically, capnography devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America capnography devices market driven by increase in the prevalence of respiratory failures (according to American Thoracic Society, approximately 360,000 respiratory failure cases observed every year in the use), increase in the R&D activities for the innovation of newer products, and FDA clearance for newer products and platforms in the market. Europecapnography devices market is projected to grow at a significant rate, which is attributed to recommendations for adoption by European Resuscitation Council (ERC), Association of Anaesthetists of the Great Britain & Ireland (AAGBI), and Intensive care Society in U.K. Asia Pacific capnography devices market is growing due to increase in geriatric population, which leads to increase in the prevalence of respiratory disorders and government initiations for the development of healthcare facilities are bolster the market. Middle East and Africa capnography devices market growth attributed to the launching of newer products into Middle East region. For instance, in January 2015, Viamed launched new capnograph monitor technology VersaStream to Middle East regions at Arab Health 2015.

  Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/capnography-devices-market/#ulp-14mlyhjMGhVjZqa3

   Competition Assessment: Capnography Devices Market

Some of the players in the global capnography devices market include:

·         Covidien plc (Medtronic, plc. (Ireland))

·         Masimo Corporation (U.S.)

·         Nihon Kohden Corporation (Japan)

·         Smiths Medical, Inc. (U.S.)

·         Nonin Medical, Inc. (U.S.)

·         Welch Allyn Inc. (U.S.)

·         Koninklijke Philips N.V. (Netherlands)

·         Dragerwerk AG & Co. KGaA (Germany)

·         Viamed Limited (England)

·         Salter Labs (U.S.)

 Notable Market Developments: Capnography Devices Market

·         In August 2017, Salter Labs acquired IntuBrite, Parker Medical, Innomed Technologies for expanding the Airway product portfolio including Capnography devices

   Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012 to 2016) and forecast (2017 to 2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

  Get access to full summary @

 https://www.precisionbusinessinsights.com/market-reports/capnography-devices-market/

 About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 Contact to Precision Business Insights,

 Kemp House,

 152 – 160 City Road,

 London EC1V 2NX

 Email: sales@precisionbusinessinsights.com

 Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Bulk Food Ingredients Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Market Outline: Bulk Food Ingredients Market 

Bulk food ingredients are the components that are used in ready to eat foods, processed and packaged foods like chocolates, biscuits etc. Bulk food ingredients include artificial sweeteners, coffee and tea, spices, herbs, dry fruits, dehydrated vegetables etc. Bulk food ingredients can also be called as whole food ingredients and can be found in organic form.

 Market dynamics: Bulk Food Ingredients Market 

Increasing demand for the packed food and convenience food is the major factor which is driving the market revenue growth of the bulk food ingredients market. Furthermore, change in consumer lifestyles, growing health consciousness among the consumers, rise in disposable income, growing trend of consuming ready to cook food, high consumption of beverages, snacks and processed food, increase in working woman population are also propelling the growth of the bulk food ingredients market globally. However, strict regulatory framework, high cost of the products and unbalanced agriculture supply are the few factors which are restraining the growth of the market.

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/bulk-food-ingredients-market/#ulp-4H8Z4LpNMLEuOnnx

    Market Scope: Bulk Food Ingredients Market 

The bulk food ingredients market is classified on the basis of type, application and geographical regions.

Based on type, it is segmented as

·         Primary

o    Nuts

o    Grains, Cereals and Pulses

o    Oil Seeds

o    Spices and Herbs

o    Tea and Coffee

o    Sugar and Salt

o    Others

·         Secondary

o    Processed Nuts and Dry Fruits

o    Processed Spices and Herbs

o    Sea Salt

o    Flour

Based on application, it is segmented as

·         Bakery and confectionary products

·         Food

·         Ready to eat/cook meals

·         Snacks and spreads

·         Alcoholic and Non-alcoholic Beverages

·         Others

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/bulk-food-ingredients-market/#ulp-c654SbFYO64MsOhu

   Market Summary: Bulk Food Ingredients Market 

Few ingredients in food ingredients market are experiencing rapid growth. Bulk food ingredients market is more complex and fragmented. Market players need to adopt changes according to consumer preferences in order to hold top positions. Growing safety and health concerns regarding processed foods is the most challenging issue for the market players to exist strongly in the bulk food ingredients market. Market players are focussing on the expansions, investments, mergers and acquisitions, collaborations and partnerships, new product launches in order to make their strong presence in the ingredients market.

 Regional Analysis: Bulk Food Ingredients Market 

Geographically bulk food ingredients market is segmented into Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. Due to the growing disposable income in emerging countries, rapid urbanization in the developing countries, adoption of the western lifestyle, increase in consumption of the processed food and canned food are the major factors attributed to the significant growth of bulk food ingredients market in Asia Pacific region especially in countries like India, China, New Zealand and Australia. North America and Europe hold a very significant position in the bulk food ingredients market owing to the high consumption of processed and canned food, growing demand for the low fat and low cholesterol food, growing health concerns among the consumers etc.

 Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/bulk-food-ingredients-market/#ulp-14mlyhjMGhVjZqa3

   Market participants: Bulk Food Ingredients Market 

Some of the players in Market are Dupont (U.S), Olam International (Singapore), Associated British Foods (UK), Archer Daniels Midland Company (U.S), DMH Ingredients( U.S), Ingredion Incorporated(U.S), Cargill Inc. (U.S). to name a few

 Notable Market Developments: Bulk Food Ingredients Market

·         In October 2015, Olam International has acquired global cocoa business of ADM (Archer Daniel Midland Co.) to increase their market revenue and strengthen their global market presence.

  Key Features of the Report

·         The report provides granular level information about The market size, regional market share and forecast from 2017-2023

·         The report covers in-detail insights about The competitor’s overview, key findings and Their key strategies

·         The report outlines drivers, restraints, challenges, and trends that are currently faced by The industry

·         The report tracks recent innovations, key developments and startup’s details that are working in The industry

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

  Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/bulk-food-ingredients-market/

  About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 Contact to Precision Business Insights,

 Kemp House,

 152 – 160 City Road,

 London EC1V 2NX

 Email: sales@precisionbusinessinsights.com

 Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Breast Lesion Localization Methods Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Global Breast Lesion Localization Methods Market: By Technology (Radio Isotope Localization (Radio Isotope Seed Localization (RSL), Radio Occult Lesion Localization (ROLL), Others), Wire Guided localization, Magnetic Tracker, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASC’s), and Others), By Region (North America, Asia Pacific, Latin America, Europe, Middle East and Africa) – Breast Lesion Localization Methods Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

 Market Outline: Global Breast Lesion Localization Methods Market

 Breast cancer is characterized by the abnormal multiplication of the breast cells that will form lumps that may be nonmalignant or malignant in nature. Such abnormal breast cells usually form tumors that may often observe on x-ray. Breast cancer occurs commonly in woman above 40 years of age and often it can be seen in men also. For the early detection of the lumps or lesions, various methods are used. Breast lesion localization methods are used to detect the nonpalatable suspicious breast lesions during the biopsy.

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/breast-lesion-localization-methods-market/#ulp-4H8Z4LpNMLEuOnnx

 Market dynamics: Global Breast Lesion Localization Methods Market

The advent of the novel technologies in breast localization methods such as electromagnetic reflectors and magnetic trackers and prevalence of the breast cancer worldwide are driving the breast lesion localization methods market. In addition, increase in awareness about the early detection of breast cancer due to the different awareness campaigns and initiatives were taken by respective government and nonprofit organizations such as Canadian Breast Cancer Foundation, American Cancer Society, and World Health Organization (WHO) expected to boost the market growth further. Moreover, favorable reimbursement policies in developed countries coupled with the rising demand for the better healthcare infrastructure globally projected to bolster the market growth over the forecast period. However, stringent regulatory approvals and high cost of the devices anticipated to hamper the global breast lesion localization market over the coming years.

 Market Scope: Global Breast Lesion Localization Methods Market

Breast Lesion Localization Methods market is segmented based on technology, end user, and geography

Based on technology, market is segmented into

·         Radio Isotope Localization

o    Radio Isotope Seed Localization (RSL)

o    Radio Occult Lesion Localization (ROLL)

o    Others

·         Wire Guided localization

·         Magnetic Tracker

·         Others

Based on end user, market is segmented into

·         Hospitals

·         Ambulatory Surgical Centers (ASC’s)

·         Others

Based on region, market is segmented into

·         North America

·         Latin America

·         Asia Pacific

·         The Middle East and Africa (MEA)

·         Europe

 To view TOC of this report is available upon request @

 https://www.precisionbusinessinsights.com/market-reports/breast-lesion-localization-methods-market/#ulp-c654SbFYO64MsOhu

 Market Summary: Global Breast Lesion Localization Methods Market

Breast lesion localization methods market is growing at significant rates owing to the rise in prevalence of the breast cancer. According to GLOBOCAN 2012 data, breast cancer is the second most common cancer worldwide, accounting 11.9% cancer cases globally. An estimated, 1.7 million new cases were diagnosed in 2012. Companies operating in the global breast lesion localization methods market are focusing on the development of the new technologies to increase their market share. For instance, Cianna Medical Inc. has received U.S. Food and Drug Administration for its SAVI SCOUT radar localization system. SAVI SCOUT is an integral part of SCOUT system for integral localization. Furthermore, companies also adopting the acquisitions and mergers to strengthen their product portfolio and market position. For instance, in September 2016, Argon Medical Inc. acquired soft tissue biopsy instruments manufacturer, Promex Technologies, LLC to strengthen its portfolio in soft tissue biopsy instruments including breast localization needles.

 Regional Analysis: Global Breast Lesion Localization Methods Market

Geographically breast lesion localization methods market is divided into five key regions, i.e. North America, Europe, Asia- Pacific, Latin America, and the Middle East & Africa. North America breast lesion localization methods market is expected to grow at significant rates owing to lifestyle changes and the rise in the prevalence rates of breast cancer. Furthermore, established healthcare infrastructure and growing awareness related to the early detection of cancer are expected to boost the market growth in North America region. Europe breast lesion localization methods market is projected to grow t high rates owing to the increase in incident rates of breast cancer and advancements in technology. According to the GLOBCON 2008 report by WHO, the incident rates of breast cancer is 89.7 per 100,000 women in Western Europe, which is highest incident rate in the world. Asia Pacific breast lesion localization methods market is expected to have lucrative growth opportunity due to developing healthcare infrastructure and rise in breast cancer cases. Furthermore, rise in disposable income, growing awareness regarding early detection of cancer.

 Need more information about this report @

 https://www.precisionbusinessinsights.com/market-reports/breast-lesion-localization-methods-market/#ulp-14mlyhjMGhVjZqa3

  Competition Assessment: Global Breast Lesion Localization Methods Market

Some of the players in breast lesion localization methods market are

·         Cianna Medical, Inc. (U.S.)

·         STERYLAB (Italy)

·         Cook Group Inc. (U.S.)

·         SOMATEX Medical Technologies GmbH (Germany)

·         CP Medical, Inc. (Theragenics Corporation) (U.S.)

·         R. Bard, Inc. (U.S.)

·         Argon Medical Devices, Inc. (ACI Medical Devices, Inc.) (U.S.)

·         Faxitron, Inc. (Faxitron Bioptics, LLC) (U.S.)

·         Endomagnetics Limited. (UK)

 Notable Market Developments: Global Breast Lesion Localization Methods Market

·         In May 2017, U.S. Food and Drug Administration has approved LOCalizer radio frequency identification lesion localization system of Faxitron, Inc.

 Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

  Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/breast-lesion-localization-methods-market/

About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Contact to Precision Business Insights,

 Kemp House,

152 – 160 City Road,

London EC1V 2NX

 Email: sales@precisionbusinessinsights.com

 Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Branded Generics In Emerging Countries: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Branded Generics In Emerging Countries:

By Disease Indication (Cardiovascular Diseases, Diabetes, Cancer, Neurological Disorders, Gastrointestinal Diseases, Dermatology Diseases, and Others), By Route of Administration (Oral, Parenteral, Topical, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Branded Generics in Emerging Countries Report Description:

 Branded Generics in Emerging Countries report gives the comprehensive outlook on branded generics across the emerging countries with special emphasis on key regions such as BRICS, ASEAN, and Latin America regions. This report on branded generics in emerging countries gives historical, current, and future market sizes (US$ Mn) of disease indications, route of administration, distribution channels, and geographic regions. This report studies branded generics market dynamics in emerging countries elaborately to identify the current trends & drivers, future market opportunities and possible challenges to the key stakeholders operating in the market. In addition, branded generics in the emerging countries report includes new product introductions, recent drug patent expiration data, regulatory scenario, collaborations & distribution agreements and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the branded generics market in emerging countries to better equip the clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Disease Opportunities). Key stakeholders of the branded generics in emerging countries report include suppliers, manufacturers, marketers, engaged in manufacturing and supply of pharmaceutical products.

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/branded-generics-in-emerging-countries/#ulp-4H8Z4LpNMLEuOnnx

  Branded Generics in Emerging Countries:

 The Branded Generics Market in Emerging countries estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017 to 2023. The market for branded generics projected to reach US$ XX Mn by 2023 owing to rise in out-of-pocket healthcare expenditure and availability of large untapped market.

 Rise in out-of-pocket healthcare expenditure and vast market opportunities expected to drive market revenue growth significantly

 The healthcare spending as % of total private healthcare expenditure is high in major countries such as India, China, and Brazil, which is likely to impact market growth positively over the forecast period. For instance in 2014, According to World Bank global health expenditure database, Out-of-pocket health expenditure (% of private expenditure on health) in India and China were 89.2% and 72.3% respectively. Moreover, several countries in emerging markets witnessing growing middle-class and rise in incomes, which is expected to create significant demand for branded generics in the emerging countries. In addition, emerging countries account for more than 50% of branded generics sales across the globe, this helps the multinational and local pharmaceutical companies to capitalize the ever-growing market opportunities in the region.

 Governments pushing for low-cost drugs to improve market access

 The rising demand for affordable and high-quality medicines in emerging countries and local government’s initiative improve the healthcare access by means of building healthcare infrastructure and price regulations paving the way for branded generics, which enjoys loyalty from larger stakeholders. Moreover, the mixed demographic profile, rising chronic diseases creating the demand for high quality branded drugs in the emerging countries. However, unique players need to understand the unique challenge of access and affordability in the region to withstand current market competition and to derive the long-term strategy.

    To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/branded-generics-in-emerging-countries/#ulp-c654SbFYO64MsOhu

  Asia-Pacific region leads the market with higher revenue share and growth

 Asia-pacific region leads the branded generics market in emerging countries in terms of revenue in 2016 and projected to remain dominant across the forecast period owing to high out-of-pocket healthcare expenditure, rising prevalence of chronic diseases, and growing middle-class population. Latin America presented better growth opportunities for the market players.

 Competition Assessment

 Key players profiled in the global Branded Generics in Emerging Countries include:

·         Abbott Laboratories (U.S.)

·         Apotex Inc. (Canada)

·         AstraZeneca (U.K)

·         CSPC Pharmaceutical Group Limited. (China)

·         Reddy’s Laboratories Ltd. (India)

·         GlaxoSmithKline plc (U.K)

·         Mylan N.V. (U.S.)

·         Novartis AG (Switzerland)

·         Pfizer Inc. (U.S)

·         Sanofi (France)

·         Sun Pharmaceutical Industries Ltd. (India)

·         Teva Pharmaceutical Industries Ltd (Israel)

·         Valeant Pharmaceuticals International, Inc. (Canada)

·         Nichi-Iko Pharmaceutical Co., Ltd ( Japan)

 Market players are focusing on mergers and acquisitions to improve their market position in emerging countries. For instance, in 2016, Sun pharma acquired Russian drug maker Biosintez as to step up focus on emerging countries.

     Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/branded-generics-in-emerging-countries/#ulp-14mlyhjMGhVjZqa3

 Key Findings of the Report:

 ·         Branded Generics Countries in emerging countries expanding at XX% CAGR over 2017 to 2013 to reach market value of US$ XX Mn by 2023

·         Based on diseases indication, cardiovascular diseases sub-segment accounted for larger market share in 2016 and projected to dominate throughout the forecast period

·         Retail pharmacies are prime distribution channels for branded generics in emerging countries owing to wider accessibility

·         Players focusing on mergers and acquisitions to expand geographic presence to garner market opportunities in developing economies

Key Features of the Report:

 ·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Detailed Segmentation

 By Diseases Indication

·         Cardiovascular Diseases

·         Diabetes

·         Cancer

·         Neurological Disorders

·         Gastrointestinal Diseases

·         Dermatology Diseases

·         Others

 By Route of Administration

·         Oral

·         Parenteral

·         Topical

·         Others

 By Distribution Channel

·         Hospital Pharmacies

·         Retail Pharmacies

·         Drug Stores

·         Online Pharmacies

 Geography

·         Asia-Pacific

o    China

o    India

o    ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)

o    Rest of Asia- Pacific

·         Latin America

o    Brazil

o    Poland

o    Argentina

o    Mexico

o    Venezuela

o    Rest of Latin America

·         Europe

o    Russia

o    Romania

o    Rest of Europe

·         Rest of the World (RoW)

o    Turkey

o    Saudi Arabia

o    South Africa

o    Egypt

  Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/branded-generics-in-emerging-countries/

 About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Contact to Precision Business Insights,

 Kemp House,

152 – 160 City Road,

London EC1V 2NX

 Email: sales@precisionbusinessinsights.com

 Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[coolvoidunknown-blog]

Brain Health Supplements Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Brain Health Supplements Market: Brain health supplements are used to boost the brain function by enhancing the properties such as memory, mood, attention, creativity and motivation in healthy individuals. These may be defined as the dietary supplements that either stimulate, inhibits or support the brain chemistry in order to improve the brain function. Many of the product supplements are available for the brain health in natural or synthetic forms.

 Global brain health supplements market is mainly driven by the health concerns of parents towards the enhancement of child brain potential. In addition, growing demand for brain health supplements as public interest in improve and maintain the mental health for good quality of life coupled with the growing ageing population that require brain boosters are expected to fuel the market growth during the forecast period. Furthermore, increase in awareness related to brain health supplements and its advantages also contribute to growth of the market. However, less awareness in underdeveloped and developing regions and high prices of the products may hamper the brain health supplements market over the forecast period. In addition, customer vulnerability and perceptions such as presence of side-effects may impede the brain health supplement market.

Global brain health supplements market is segmented based on type, application and distribution channel

   A sample of this report is available upon request @

 https://www.precisionbusinessinsights.com/market-reports/brain-health-supplements-market/#ulp-4H8Z4LpNMLEuOnnx

 Based on type, brain health supplements market is segmented into

 ·         Protein Powder

·         Lecithin

·         Cephalin

·         Others

 Based on application, brain health supplements market is segmented into

 ·         Elder

·         Children

·         Student

·         Others

 Based on distribution channel, brain health supplements market is segmented into

 ·         Super Marts & HyperMarts

·         Online Stores

·         Drug Stores

·         Others

  To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/brain-health-supplements-market/#ulp-c654SbFYO64MsOhu

  Market is highly fragmented due to the presence of more number of market players. Companies are focussed on the development of innovative products and adapting the inventive strategies to increase the market share. For instance, in February 2017, Mind Your Zen launched three new dietary supplements for brain health, Zen Mind, Zen Mood, and Zen Sleep to help individuals support physical and mental wellbeing. Similarly, in September 2016, Trace Minerals Research (TMR) launched children brain supplement Feed My Brain (FMB), a fruit punch- flavoured chewable wafer. Furthermore, companies expanding geographical presence by entering into new regions and with collaborations & acquisitions. For instance, in January 2015, Synergy Strips Corp. acquired America’s most popular brain health supplement brand FOCUSfactor, from the Factor Nutrition Labs LLC.

 Geographically, brain health supplements market is segmented into five regions i.e. Latin America, Asia-Pacific, Europe, North America, and the Middle East & Africa. North America brain health supplements market expected to grow at significant rates owing to the factors such as growing adaptation of brain health supplements and rising awareness related to benefits of brain supplements. Market players are concentrated on developing the novel supplements and expanding the product portfolio with product launches to obtain a competitive advantage. In July 2011, Nutrilite Health Institute a subsidiary of Amway Inc., launched new brain supplement, Nutrilite Memory Builder in North America. Asia-Pacific brain health supplements market is expected to grow at significant rates owing to factors such as changing lifestyle, growing awareness and interest in brain health supplements for boosting the brain function. Europe market projected to have notable growth rate due to presence of the key market players and growing interest in public on usage of brain supplements.

 Need more information about this report @

 https://www.precisionbusinessinsights.com/market-reports/brain-health-supplements-market/#ulp-14mlyhjMGhVjZqa3

 Key Features of the Report

 ·         The report provides granular level information about The market size, regional market share and forecast from 2017-2023

·         The report covers in-detail insights about The competitor’s overview, key findings and Their key strategies

·         The report outlines drivers, restraints, challenges, and trends that are currently faced by The industry

·         The report tracks recent innovations, key developments and startup’s details that are working in The industry

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

   Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/brain-health-supplements-market/

   About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Contact to Precision Business Insights,

 Kemp House,

152 – 160 City Road,

London EC1V 2NX

 Email: sales@precisionbusinessinsights.com

 Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com